Karyopharm Therapeutics Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2023
Total Assets: $240.4M
Liabilities Breakdown FY2023
Total Liabilities: $376.6M
Asset Breakdown
Total Assets: $240.4M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $52.2M | 21.7% |
| Accounts Receivable | $27.0M | 11.2% |
| Inventory | $3.0M | 1.3% |
| Property, Plant & Equipment | $606.0K | 0.3% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $157.6M | 65.5% |
Liabilities Breakdown
Total Liabilities: $376.6M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $3.1M | 0.8% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $373.5M | 99.2% |